Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy
Launched by ESRA NUR ERDOĞAN · Dec 1, 2024
Trial Information
Current as of July 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Gynaecological cancers, which have an important place among the cancers seen both in the world and in our country, are malignant tumours of the female reproductive organ. In the treatment of gynaecological cancers, many methods such as chemotherapy, radiotherapy, surgical treatment, hormone therapy are used alone or together. Chemotherapy, which is one of the most commonly used and basic methods in cancer treatment, causes many physical and psychological side effects while treating the disease. However, side effects may not occur at the same time and some may develop after discharge. Theref...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Receiving chemotherapy for the first time due to gynaecological cancer and completing the first chemotherapy course
- • At least 18 years old
- • Not previously diagnosed with cancer, diagnosed with gynaecological cancer for the first time and only
- • Literate
- • Who agreed to participate in the research
- • No communication barrier
- • Eastern Cooperative Oncology Group (ECOG) Performance Scale score below 3
- • No diagnosed psychiatric illness
- • Women who have an Android or IOS smartphone and can access the internet
- Exclusion Criteria:
- • The investigator discontinued the treatment
- • Chemotherapy treatment discontinued after the start of the study
- • Not actively using the mobile application
- • Not filling in the forms during the use of the Mobile Application
- • The occurrence of another cancer during the research
About Esra Nur Erdoğan
Esra Nur Erdoğan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on ethical standards and regulatory compliance, Erdoğan leads initiatives that aim to explore new therapies and enhance existing treatment protocols across various therapeutic areas. Her expertise in trial management, combined with a collaborative approach, fosters partnerships with healthcare professionals and research institutions, ensuring the successful execution of clinical studies that contribute to the advancement of medical knowledge and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Esra Nur Erdoğan, PhD Student
Study Chair
University of Health Sciences Gulhane Faculty of Nursing, Department of Obstetrics and Gynaecology
Gülten Güvenç, Prof.Dr.
Principal Investigator
University of Health Sciences Gulhane Faculty of Nursing, Department of Obstetrics and Gynaecology
Tülay Eren, Asst. Prof.
Study Chair
Etlik City Hospital, Medical Oncology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported